Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

Published by
Matej Mikulic,
May 20, 2020
It is estimated that from 2019 to 2024 the CAGR of the demand for pharmaceutical specialy excipients will be approximately 6.5 percent in a best case scenario. The growth between 2019 and 2020 will probably be around -1.5 percent due to the impact of the coronavirus.

Forecasted CAGR for pharmaceutical specialty excipient demand due to COVID-19 worldwide in 2019-2024*

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2020

Region

Worldwide

Survey time period

as of May 2020

Supplementary notes

* For oral solid dosage forms (OSDF).

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu